Raymond Dalgleish studied for an undergraduate degree in Cell Biology at the University of Glasgow. However, a stint as a summer student in 1975 at the Beatson Institute for Cancer Research in Glasgow convinced Raymond that his real interest lay in human molecular genetics, which led to him completing a PhD in 1980 at St Mary's Hospital Medical School, London, under the supervision of Professor Bob Williamson, cloning human globin cDNA and gene sequences.
In 1980, Raymond was awarded a Fogarty International Fellowship to allow him to undertake postdoctoral studies at the National Institutes of Health, Bethesda, Maryland, USA. Working in the Pulmonary Branch of the National Heart Lung and Blood Institute, Dr Dalgleish cloned and analysed cDNA and genomic sequences for human collagen types I and III.
In 1984, Dr Dalgleish was appointed to the post of lecturer in the then Department of Genetics at the University of Leicester, continuing to work on collagen genes specifically with respect to sequence variants that result in inherited connective tissue disorders.
Professor Dalgleish is currently emeritus professor of human genetics and has latterly developed a close interest in bioinformatics relating to human heritable disease.
Garibaldi N, Besio R, Dalgleish R, Villani S, Barnes AM, Marini JC, Forlino A (2022) Dissecting the phenotypic variability of Osteogenesis Imperfect. Disease Models & Mechanisms, in press
Bruford E, Antonescu CR, Carroll AJ, Chinnaiyan A, Cree IA, Cross NCP, Dalgleish R, Gale RP, Harrison CJ, Hastings RJ, Huret J-P, Johansson B, Le Beau M, Mecucci C, Mertens F, Mitelman F (2021) HUGO Gene Nomenclature Committee (HGNC) recommendation for the designation of gene fusions. Leukemia, 35, 3040-3043. DOI 10.1038/s41375-021-01436-6.
Leske H, Dalgleish R, Lazar AJ, Reifenberger G, Cree IA (2021) A common classification framework for histone sequence alterations in tumours: an expert consensus proposal. Journal of Pathology, 254,109-120. DOI 10.1002/path.5666.
Higgins J, Dalgleish R, den Dunnen JT, Barsh G, Freeman PJ, Cooper DN, Cullinan S, Davies KE, Dorkins H, Gong L, Imoto I, Klein T, Korf B, Misra A, Ratzel S, Reichardt JKV, Rehm HL, Tokunaga K, Weck KE, Cutting GR (2021) Verifying nomenclature of DNA variants in submitted manuscripts: guidance for journals. Human Mutation, 42, 3-7. DOI 10.1002/humu.24144.
Fratter C, Dalgleish R, Allen SK Santos R, Abbs S, Tuffery-Giraud S, Ferlini A. (2020) Best practice guidelines for genetic testing in dystrophinopathies. European Journal of Human Genetics, 28, 1141-1159. DOI 10.1038/s41431-020-0643-7.
Wang M, Callenberg KM, Dalgleish R, Fedtsov A, Freeman PJ, Jacobs KB, Kaleta P, McMurry AJ, PrliÄ‡ A, Hart RK (2018) hgvs: A Python package for manipulating sequence variants using HGVS nomenclature: 2018 Update. Human Mutation, 39, 1803-1813. DOI 10.1002/humu.23615.
Freeman PJ, Hart RK, Gretton LJ, Brookes AJ, Dalgleish R (2018) VariantValidator: accurate validation, mapping and formatting of sequence variant descriptions. Human Mutation, 39: 61-68. 10.1002/humu.23348.
Parkin JD, San Antonio JD, Persikov A, Dagher H, Dalgleish R, Jensen ST, Jeunemaitre X, Savige J (2017) The collagen III fibril has a "flexi-rod" structure of flexible sequences interspersed with rigid bioactive domains including two with hemostatic roles. PloS One, 12: e0175582.
Dalgleish R (2016) LSDBs and how they have evolved. Human Mutation, 37: 532-539.
den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, Roux A-F, Smith T, Antonarakis SE, Taschner PEM (2016) HGVS recommendations for the description of sequence variants: 2016 update. Human Mutation, 37: 564-569.
MacArthur JAL, Morales J, Tully RE, Astashyn A, Gil L, Bruford EA, Larsson P, Flicek P, Dalgleish R, Maglott DR, Cunningham F (2014) Locus Reference Genomic: reference sequences for the reporting of clinically relevant sequence variants. Nucleic Acids Research, 42: D873-D878.